Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jaguar Health (JAGX) Intangibles (2017 - 2025)

Jaguar Health (JAGX) has disclosed Intangibles for 9 consecutive years, with $17.5 million as the latest value for Q2 2025.

  • On a quarterly basis, Intangibles fell 9.6% to $17.5 million in Q2 2025 year-over-year; TTM through Jun 2025 was $17.5 million, a 9.6% decrease, with the full-year FY2023 number at $20.1 million, down 10.35% from a year prior.
  • Intangibles was $17.5 million for Q2 2025 at Jaguar Health, down from $18.0 million in the prior quarter.
  • In the past five years, Intangibles ranged from a high of $23.0 million in Q2 2022 to a low of $16.7 million in Q2 2023.
  • A 5-year average of $20.0 million and a median of $19.8 million in 2023 define the central range for Intangibles.
  • Peak YoY movement for Intangibles: fell 27.52% in 2023, then grew 16.47% in 2024.
  • Jaguar Health's Intangibles stood at $22.7 million in 2021, then fell by 0.94% to $22.4 million in 2022, then fell by 10.35% to $20.1 million in 2023, then dropped by 5.81% to $18.9 million in 2024, then decreased by 7.4% to $17.5 million in 2025.
  • Per Business Quant, the three most recent readings for JAGX's Intangibles are $17.5 million (Q2 2025), $18.0 million (Q1 2025), and $18.9 million (Q3 2024).